Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development

Who May Qualify: - Patients in the inpatient department or the outpatient department - Patients need to have at least one electrocardiogram within one year Who Should NOT Join This Trial: - Diagnosis of atrial fibrillation/atrial flutter - History of atrial fibrillation/atrial flutter catheter ablation - Patients with cardiac implantable electronic devices - Any documented electrocardiogram showed atrial fibrillation/atrial flutter and pacing rhythm - History of received rhythm control medications for atrial arrhythmia, including Class I and Class III antiarrhythmic drugs - Any reasons indicate for anti-coagulant agents, including vitamin K antagonist and non-vitamin K antagonist oral anticoagulant Always talk to your doctor about whether this trial is right for you.